The trademark 3PInnovation was filed by Samsung Biologics Co., Ltd., a corporation established under the laws of the Republic of Korea (the "Applicant"). The application was published for oppositions on May 14, 2020, and received one opposition filed on August 6, 2020 by 3P BIOPHARMACEUTICALS, S.L. on Likelihood of confusion. the opponent was represented by AB ASESORES and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued August 6, 2020
The application was filed in English, and English was also language of all opposition proceedings (French was selected as the second language).
Goods And Services
The mark was filed in class 40 with following description of goods:
Custom manufacture of biopharmaceuticals
Processing of medicinal materials
Custom manufacture of pharmaceuticals
Processing of pharmaceutical preparations
Preservation of pharmaceuticals
Processing of medical products
Production of cell line for the manufacture of biopharmaceutical
Processing of chemicals
Processing of biopharmaceutical materials
Treatment of biopharmaceutical materials
Chemical treatment of liquids.
The mark was filed in class 42 with following description of goods:
Crude medicines research
Development of cell therapy products
Development of pharmaceutical preparations and medicines
Pharmaceutical products development
Inspection of pharmaceuticals
Research relating to medicines
Clinical testing of medicines
Pharmaceutical products evaluation
Research for medical products
Bacteriological research and analysis
Medical laboratory services
Stem cell research services
Clinical research
Medicine research
Research and development of technology for biotechnology
Research and development of technology
Microbial culture trials
Biochemistry research services
Genetic research
Scientific research in the field of genetic engineering.